A new study published in Biomedicine & Pharmacotherapy reports that a blend of cannabidiol (CBD) and cannabidivarin (CBDV) sharply reduces expression of a key immune receptor linked to inflammatory bowel disease. The research, conducted by scientists from the Technion-Israel Institute of Technology, offers evidence for a CB2-dependent cannabinoid interaction that may help explain the entourage …
Category: Studies
Cannabis Use Linked to Reduce Risk of Oral Cancer, New Meta-Analysis Finds
A meta-analysis published this week by the Journal of Ethnological Substance Abuse reports that cannabis use is linked to a reduced risk of oral cancer. After reviewing thousands of participants across multiple case-control studies, the analysis found that marijuana use was associated with a reduced likelihood of developing oral cancer. It was conducted by researchers …
Study: Autistic Adults Report 73% Short-Term Symptom Relief After Using Inhaled Cannabis
A new study published in Scientific Reports finds that autistic adults who use inhaled cannabis report large short-term reductions in core and co-occurring symptoms. The research was conducted by scientists from Washington State University and the University of New Orleans using anonymized data from the Strainprint journaling app.
Study: CBD Reduces Tumor Growth and Lowers Immune Evasion Marker HLA-G
A study published yesterday in the peer-reviewed journal Scientific Reports finds that cannabidiol may suppress a key immune-evasion molecule used by certain tumors while simultaneously reducing their growth and mobility. The findings come from experiments using JEG-3 choriocarcinoma cells, a model commonly used to study cancer behavior and immune-related pathways.
Study: Adult-Use Cannabis Regulators Outpace Alcohol Agencies on Public Health Goals
Adult-use cannabis regulators are more likely than alcohol agencies to describe and report their work in public health terms, according to a new analysis of state regulatory reports from the 24 U.S. states that have legalized recreational marijuana. Researchers reviewed the most recent annual reports from 22 cannabis agencies and 20 alcohol regulators, looking for …
CBD-Rich Cannabis Extract Shows Strong Immunomodulatory Effects in T Cell Study
A new laboratory study published in the International Journal of Molecular Sciences reports that a cannabidiol-rich cannabis extract known as CAN296 produced strong and consistent immunomodulatory effects when tested on human T cells. Researchers from the Technion-Israel Institute of Technology and the Hebrew University of Jerusalem evaluated how the extract altered activation markers, cytokine levels, …
Study: Cannabis Extract Shows Strong Lethal and Repellent Effects Against Chagas Disease Vector
A new study reports that cannabis-derived extracts may offer an effective, low-toxicity option for controlling Triatoma infestans, the primary insect responsible for spreading Chagas disease. Researchers evaluated extracts taken from the inflorescences of a Deep Mandarine cannabis variety and found notable lethal and repellent activity against fifth-instar nymphs of the insect, even outperforming widely used …
CBD May Reduce Some Cellular Harms from Doxycycline Exposure, Study Finds
A new laboratory study examining how cannabidiol interacts with doxycycline suggests CBD could soften some of the antibiotic’s toxic effects in certain human cell types. The findings add to a growing body of work looking at how plant-derived compounds may influence the way pharmaceuticals behave once they enter the body or the food chain.
Study: Cannabinoids Like CBGA, CBN, and CBG May Reduce HIV-Related Pain
Researchers at the University of Mississippi have found that several minor cannabinoids may help alleviate HIV-associated pain, offering potential new directions for personalized treatment. The study, published in NeuroImmune Pharmacology and Therapeutics, explored how cannabinoids interact with the HIV-1 regulatory protein Tat, which plays a role in chronic pain among people living with HIV (PLWH). …
Study: Cannabidiol Suppresses Tumor Growth in Colon Cancer by Targeting Metabolic Pathways
Researchers in China have found that cannabidiol (CBD) may inhibit colon cancer progression by disrupting the tumor’s altered metabolic activity, offering a potential new strategy for treating colon adenocarcinoma (COAD). In the study, published in the American Journal of Chinese Medicine and conducted by researchers at The Affiliated Central Hospital of Shenyang Medical College and …
Sponsored
